[PDF][PDF] Correlation of NPM1 type A mutation burden with clinical status and outcomes in acute myeloid leukemia patients with mutated NPM1 type A
SY Jo, SH Park, IS Kim, J Yi, HH Kim… - Annals of laboratory …, 2016 - synapse.koreamed.org
Background: Nucleophosmin gene (NPM1) mutation may be a good molecular marker for
assessing the clinical status and predicting the outcomes in AML patients. We evaluated the …
assessing the clinical status and predicting the outcomes in AML patients. We evaluated the …
Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogenetique hematologique (GFCH)
I Luquet, A Bidet, W Cuccuini… - Annales de Biologie …, 2016 - jle.com
The karyotype is critical for the evaluation of acute myeloid leukemia (AML) at diagnosis.
Cytogenetic abnormalities detected in AML are one of the most powerful independent …
Cytogenetic abnormalities detected in AML are one of the most powerful independent …
[PDF][PDF] Place de la cytogénétique dans la prise en charge des leucémies aiguës myéloïdes: Actualisation par le Groupe francophone de cytogénétique hématologique …
I Luquet, A Bidet, W Cuccuini, M Lafage-Pochitaloff… - Ann. Biol. Clin, 2016 - eaclf.org
Le caryotype est un examen indispensable lors de l'évaluation d'une leucémie aiguë
myéloïde (LAM) au diagnostic car les anomalies cytogénétiques détectées constituent l'un …
myéloïde (LAM) au diagnostic car les anomalies cytogénétiques détectées constituent l'un …
Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification
G Michel, R Cunha, A Ruggeri, TA O'Brien… - Leukemia, 2016 - nature.com
4 National Cancer Data Base. Available from https://www. facs. org/quality% 20pro
grams/cancer/ncdb (accessed date 24 March 2015). 5 Schemper M, Wakounig S, Heinze G …
grams/cancer/ncdb (accessed date 24 March 2015). 5 Schemper M, Wakounig S, Heinze G …
Introduction: childhood leukemia
A Medina-Sanson - Etiology of Acute Leukemias in Children, 2016 - Springer
Childhood leukemia is universal, with the same molecular mechanisms at play in children of
different genetic and environmental backgrounds. Leukemia is regional as well, and the …
different genetic and environmental backgrounds. Leukemia is regional as well, and the …
Relapsed childhood acute myeloid leukemia patient with inversion of chromosome 16 harboring a low FLT3 internal tandem duplication allelic burden and KIT …
A Yamada, H Moritake, M Kinoshita… - Pediatrics …, 2016 - Wiley Online Library
Abstract Inversion of chromosome 16 [inv (16)] has a good prognosis in acute myeloid
leukemia (AML), but additional genetic aberrations influence the outcome. We herein …
leukemia (AML), but additional genetic aberrations influence the outcome. We herein …
Fluorescence in situ hybridization: diagnostic tool for hematological malignancies
KL Sánchez, NH Aguilar… - Revista Cubana de …, 2016 - medigraphic.com
Introduction: hematological neoplasias have clonal origin and are characterized by great
genetic heterogeneity. The development of molecular cytogenetic through fluorescence in …
genetic heterogeneity. The development of molecular cytogenetic through fluorescence in …
Akutna mijeloična leukemija u djece: analiza kliničkih i bioloških značajki te rezultata liječenja u Klinici za pedijatriju Kliničkog bolničkog centra Rijeka
J Roganović, T Čučak, I Seili-Bekafigo… - Medicina Fluminensis …, 2016 - hrcak.srce.hr
Akutna mijeloična leukemija u djece: analiza kliničkih i bioloških značajki te rezultata liječenja u
Klinici za pedijatriju Page 1 http://hrcak.srce.hr/medicina medicina fluminensis 2016, Vol. 52, No …
Klinici za pedijatriju Page 1 http://hrcak.srce.hr/medicina medicina fluminensis 2016, Vol. 52, No …